Literature DB >> 8462491

Systemic effects of generalized convulsive status epilepticus.

N Y Walton1.   

Abstract

Generalized convulsive status epilepticus (GCSE) is accompanied by a marked increase in plasma catecholamines. This produces a number of changes in general systemic physiology including hypertension, tachycardia, cardiac arrhythmias, hyperglycemia, acidosis, and hyperpyrexia. If SE is stopped quickly, these changes are self-correcting and do not produce an increased risk of neuropathology. However, if seizures continue, many of the early physiologic changes reverse, and late status epilepticus is marked by hypotension, hypoglycemia, pulmonary edema and a continued acidosis and elevation of body temperature. Prevention of serious hypoglycemia, maintenance of adequate systemic blood pressure to provide adequate cerebral perfusion, and normalizing the body temperature will minimize or prevent neuropathologic sequelae to SE of extended duration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462491     DOI: 10.1111/j.1528-1157.1993.tb05906.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  What is specialized care in status epilepticus and in which ICU?

Authors:  Sophie Demeret; Nicolas Weiss; Francis Bolgert; Vincent Navarro
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

3.  Hypoglycemia-induced convulsive status epilepticus as the initial presentation of primary hepatic carcinoma.

Authors:  Limin Wu; Jiang Wu; Hongliang Zhang
Journal:  Neurol Sci       Date:  2012-03-02       Impact factor: 3.307

Review 4.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

5.  Elevation of Cardiac Troponins in Prolonged Status Epilepticus: A Retrospective Chart Analysis.

Authors:  Ng Soundarya; Dm Lawrence; Jb Samip; Av Stacy; Jc Robert; Rt Leroy; Rt Alan
Journal:  SOJ Neurol       Date:  2014

6.  Methods for ECG evaluation of indicators of cardiac risk, and susceptibility to aconitine-induced arrhythmias in rats following status epilepticus.

Authors:  Steven L Bealer; Cameron S Metcalf; Jason G Little
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

Review 7.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

8.  A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.

Authors:  Weiwei Yen; John Williamson; Edward H Bertram; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2004-03       Impact factor: 3.045

9.  Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation.

Authors:  L Forbes S Barnwell; Joaquin N Lugo; Wai L Lee; Sarah E Willis; Shira J Gertz; Richard A Hrachovy; Anne E Anderson
Journal:  Epilepsia       Date:  2009-05-11       Impact factor: 5.864

10.  Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Ludovic Dalle; Corinne Appere-de-Vecchi; Jean Louis Georges; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Hager Ben Mokhtar; Juliette Audibert; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.